HomepageMedicineBioNTech and Autolus Announce Strategic Alliance to Bolster CAR-T Cell Pipeline Medicine BioNTech and Autolus Announce Strategic Alliance to Bolster CAR-T Cell Pipeline admin Posted on February 10, 2024 BioNTech will invest $200 million and get access to Autolus’ manufacturing sites. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostHow My Cat Helped Me Find Love: Dr. Karyn’s Valentine Next PostA ‘Mother’ Is Mourned by the Queer New Yorkers She Left Behind You Might Also Like Medicine Pharma Pulse 12/2/24: Retooling the ‘Gene’ Value Machine & more admin December 2, 2024 Medicine New Survey Says Digital Health Care Technology Is Benefitting Payers admin June 18, 2024 Medicine Sage and Biogen Halt Phase II Study After Novel Drug Shows No Significant Improvement in Treating Essential Tremor admin July 25, 2024 Medicine Potential Treatment Against All COVID Variants admin September 7, 2024
Medicine Sage and Biogen Halt Phase II Study After Novel Drug Shows No Significant Improvement in Treating Essential Tremor admin July 25, 2024